Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel

Journal of Clinical Oncology

Volumn 24, Issue 22, 2006, Pages 3619-3622

  Esmaeli, Bita ^a   Amin, Sapna ^a   Valero, Vicente ^a   Adinin, Rosnie ^a   Arbuckle, Rebecca ^a   Banay, Roberto ^a   Do, Kim Anh ^a   Rivera, Edgardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOCETAXEL; SILICONE; TOBRAMYCIN; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; AGED; ARTICLE; BREAST CANCER; CANALICULAR STENOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EPIPHORA; EYE LAVAGE; EYE SURGERY; FEMALE; HUMAN; LACRIMAL DUCT OCCLUSION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; BREAST TUMOR; DRUG ADMINISTRATION; HOSPITALIZATION; INCIDENCE; LACRIMAL GLAND DISEASE; MIDDLE AGED;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INCIDENCE; LACRIMAL APPARATUS DISEASES; LACRIMAL DUCT OBSTRUCTION; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TAXOIDS;

EID: 33747082962     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.4453     Document Type: Article

References (12)

1. Fezza JP, Wesley RE, Klippenstein KA: The treatment of punctal and canalicular stenosis in patients on systemic 5-FU. Ophthalmic Surg Lasers 30:105-108, 1999
2. Seiff SR, Shorr N, Adams T: Surgical treatment of punctal and canalicular fibrosis from 5-fluorouracil therapy. Cancer 56:2148-2149, 1985
3. Esmaeli B, Golio D, Lubecki L, et al: Canalicular and nasolacrimal duct blockage: An ocular side effect associated with the anti-neoplastic drug S-1. Am J Ophthalmol 140:325-327, 2005
4. Esmaeli B, Valero V, Ahmadi MA, et al: Canalicular stenosis secondary to docetaxel (Taxotere): A newly recognized side effect. Ophthalmology 108:994-995, 2001
5. Esmaeli B, Burnstine MA, Ahmadi MA, et al: Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa. Ophthal Plast Reconstr Surg 19:305-308, 2003
6. Esmaeli B, Hortobagyi G, Esteva F, et al: Canalicular stenosis secondary to weekly docetaxel: A potentially preventable side effect. Ann Oncol 13:218-221, 2002
7. Ahmadi MA, Esmaeli B: Surgical treatment of canalicular stenosis in patients receiving weekly docetaxel. Arch Ophthalmol 119:1802-1804, 2001
8. Esmaeli B, Hortobagyi GN, Esteva FJ, et al: Canalicular stenosis secondary to weekly versus every-three-weeks docetaxel in patients with metastatic breast cancer. Ophthalmology 109:1188-1191, 2002
9. Esmaeli B, Hidaji L, Adnin RB, et al: Blockage of the lacrimal drainage apparatus as a side effect of docetaxel. Cancer 98:504-507, 2003
10. Esmaeli B, Ahmadi MA, Rivera E, et al: Docetaxel secretion in tears: Association with lacrimal drainage obstruction. Arch Ophthalmol 120:1180-1182, 2002
11. Esmaeli B: Management of excessive tearing as a side effect of docetaxel. Clin Breast Cancer 5:455-457, 2005
12. Engels FK, Verweij J: Docetaxel administration schedule: From fever to tears? A review of randomized studies. Eur J Cancer 41:1117-1126, 2005